Published in Acta Pathol Microbiol Scand on January 01, 1962
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A (1997) 2.20
Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest (2006) 1.59
Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J Virol (1994) 1.56
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med (2015) 1.52
The provocation of latent lymphocytic choriomeningitis virus infections in mice by treatment with antilymphocytic serum. J Exp Med (1968) 1.46
Plaque size heterogeneity: a genetic trait of lymphocytic choriomeningitis virus. Appl Microbiol (1970) 1.45
Twp populations of T lymphocytes immune to the lymphocytic choriomeningitis virus. J Exp Med (1974) 1.27
Lymphocytic choriomeningitis infection of the central nervous system. Front Biosci (2008) 1.21
Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology (1985) 1.18
Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. J Exp Med (2006) 1.16
Defects in the immune system of mice infected with lymphocytic choriomeningitis virus. Infect Immun (1974) 1.09
The activity of T and B lymphocytes in immunity and tolerance to the lymphocytic choriomeningitis virus in mice. Immunology (1975) 1.03
Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. J Virol (2009) 0.97
Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. J Virol (2012) 0.92
The permeability of the blood-brain barrier in mice suffering from fatal lymphocytic choriomeningitis virus infection. Acta Neuropathol (1984) 0.92
Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons. J Immunol (2009) 0.85
Lymphocytic choriomeningitis virus-induced immunosuppression: evidence for viral interference with T-cell maturation. Infect Immun (1982) 0.82
A novel virus carrier state to evaluate immunotherapeutic regimens: regulatory T cells modulate the pathogenicity of antiviral memory cells. J Immunol (2008) 0.79
Immunotherapeutic relief from persistent infections and amyloid disorders. Neurology (2006) 0.77
Experimental animals and in vitro systems in the study of lymphocytic choriomeningitis virus. Bull World Health Organ (1977) 0.75
STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS. Acta Pathol Microbiol Scand (1964) 2.04
An ornithosis related antigen from a coccoid bacterium. Acta Pathol Microbiol Scand (1956) 1.46
STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 2. TREATMENT OF VIRUS CARRIER MICE BY ADOPTIVE IMMUNIZATION. Acta Pathol Microbiol Scand (1963) 1.45
STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 3. DURATION AND MAXIMAL EFFECT OF ADOPTIVE IMMUNIZATION OF VIRUS CARRIERS. Acta Pathol Microbiol Scand (1964) 1.35
STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 5. THE INDUCTION OF TOLERANCE TO THE VIRUS. Acta Pathol Microbiol Scand (1965) 1.33
STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 6. IMMUNITY CONFERRED ON TOLERANT MICE BY IMMUNE SERUM AND BY GRAFTS OF HOMOLOGOUS LYMPHOID CELLS. Acta Pathol Microbiol Scand (1965) 1.20
INABILITY OF NUCLEIC ACID ANALOGUES TO INHIBIT THE SYNTHESIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS. Acta Pathol Microbiol Scand (1965) 1.19
Serological diagnosis of ornithosis; a serological follow-up of 163 patients. Dan Med Bull (1956) 1.12
Two ornithosis complement-fixing antigens from infected yolk sacs. I. The phosphatide antigen, the virus antigen and methods for their preparation. Acta Pathol Microbiol Scand (1955) 1.11
The antigenic relationship between Ornithosis virus and Bacterium anitratum. Acta Pathol Microbiol Scand (1957) 1.06
[VIROLOGY OF THE COMMON COLD SYNDROME. A SURVEY WITH A RESUM'E OF DANISH STUDIES]. Ugeskr Laeger (1964) 0.96
Studies on ornithosis in Denmark. Acta Pathol Microbiol Scand (1954) 0.85
[Sterilization by formaldehyde ovens]. Ugeskr Laeger (1952) 0.75
[Can the hepatitis virus be cultivated?]. Nord Med (1962) 0.75
Ornithosis-related antigens from B. anitratum in the serological diagnosis of ornithosis. I. Acta Pathol Microbiol Scand (1958) 0.75
Ornithosis complement fixing antigen from infected allantoic fluid. Acta Pathol Microbiol Scand (1957) 0.75
THE INCIDENCE OF COMPLEMENT-FIXING ANTIBODIES TO THE RESPIRATORY SYNCYTIAL VIRUS IN SERA FROM DANISH POPULATION GROUPS AGED 0-19 YEARS. Acta Pathol Microbiol Scand (1964) 0.75
Studies on ornithosis complement-fixing antigens in infected yolk sac membranes. Acta Pathol Microbiol Scand Suppl (1956) 0.75
Studies on ornithosis in Denmark. Dan Med Bull (1955) 0.75
[Ornithosis (psittacosis) in Denmark; preliminary report]. Ugeskr Laeger (1954) 0.75
Two complement-fixing antigens from infected yolk sacs. II. The nature of the virus antigen and its relation to the phosphatide antigen. Acta Pathol Microbiol Scand (1955) 0.75
[VIROLOGY OF THE COMMON COLD SYNDROME. A SURVEY WITH A RESUM'E OF DANISH STUDIES]. Ugeskr Laeger (1964) 0.75